{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:06:54Z","timestamp":1784138814295,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In Canada, the legalization of cannabis has enabled cannabidiol (CBD) to become a popular commercial product, increasingly used for medical or therapeutic purposes. There are currently over one thousand CBD products available globally, ranging from oil extracts to CBD-infused beverages. Despite increased usage and availability, the evidence supporting the medical efficacy of CBD is limited. Anecdotal evidence suggests CBD sellers represent their products for medical use through direct medical claims or advice, which in Canada, is not allowed under the <jats:italic>Cannabis Act<\/jats:italic> without Health Canada approval. However, it is not clear the extent of sellers making health claims or other strategies used to promote medical usage of CBD. The objective of this study is to determine how CBD sellers advertise their products online to consumers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The product descriptions of 2165 CBD products from 70 websites selling CBD products for human consumption in Canada were collected from January 14th<jats:sup>,<\/jats:sup> 2020 to February 2nd<jats:sup>,<\/jats:sup> 2020 using an automated website scraper tool. A framing analysis was used to determine how CBD sellers frame their products to prospective customers. The specific medical conditions CBD is represented to treat and product forms were tabulated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CBD products are framed to prospective customer through three distinct frames: a specific cure or treatment (<jats:italic>n<\/jats:italic>\u2009=\u20091153), a natural health product (<jats:italic>n<\/jats:italic>\u2009=\u2009872), and a product used in certain ways to achieve particular results (<jats:italic>n<\/jats:italic>\u2009=\u20091388). Product descriptions contained medical or therapeutic claims for 171 medical conditions and ailments, with 53.3% of products containing at least one claim. The most prevalent claims found in product descriptions were the ability to treat or manage pain (<jats:italic>n<\/jats:italic>\u2009=\u2009824), anxiety (<jats:italic>n<\/jats:italic>\u2009=\u2009609), and inflammation (<jats:italic>n<\/jats:italic>\u2009=\u2009545). Claims were found for treating or managing serious and-life-threatening illnesses such as multiple sclerosis (<jats:italic>n<\/jats:italic>\u2009=\u2009210), arthritis (<jats:italic>n<\/jats:italic>\u2009=\u2009179), cancer (<jats:italic>n<\/jats:italic>\u2009=\u2009169), Crohn\u2019s disease (<jats:italic>n<\/jats:italic>\u2009=\u200978), Parkinson\u2019s disease (<jats:italic>n<\/jats:italic>\u2009=\u200959), and human immunodeficiency virus (HIV) (<jats:italic>n<\/jats:italic>\u2009=\u200954). CBD most often came in oil\/tincture\/concentrate form (<jats:italic>n<\/jats:italic>\u2009=\u2009755), followed by edibles (<jats:italic>n<\/jats:italic>\u2009=\u2009428), and vaporizer pen\/cartridge\/liquid products (<jats:italic>n<\/jats:italic>\u2009=\u2009290).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The findings suggest CBD is represented as a medical option for numerous conditions and ailments. We recommend Health Canada to conduct a systematic audit of companies selling CBD for regulatory adherence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-11282-x","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T20:03:07Z","timestamp":1625169787000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Selling cannabidiol products in Canada: A framing analysis of advertising claims by online retailers"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4201-6070","authenticated-orcid":false,"given":"Marco Antonio","family":"Zenone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valorie","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"11282_CR1","unstructured":"Davis M. What Is CBD? Live Science. Available from: https:\/\/www.livescience.com\/65811-what-is-cbd.html. Cited 2021 May 31"},{"key":"11282_CR2","unstructured":"Dorbian I. CBD Market Could Reach $20 Billion By 2024, Says New Study. Forbes. 2019 May 20. Cited 2021 May 31."},{"key":"11282_CR3","unstructured":"Williams A. Why Is CBD Everywhere? The New York Times. 2018 Oct 27. Cited 2021 May 31."},{"key":"11282_CR4","unstructured":"CBD products: favorite aspects in U.S. and abroad 2017. Statista. 2017 Dec 7. Available from: https:\/\/www.statista.com\/statistics\/789176\/cbd-products-favorite-aspects-in-us-and-abroad\/. Cited 2021 May 31."},{"issue":"5","key":"11282_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1080\/19390211.2020.1777244","volume":"17","author":"LA Walker","year":"2020","unstructured":"Walker LA, Koturbash I, Kingston R, ElSohly MA, Yates CR, Gurley BJ, et al. Cannabidiol (CBD) in dietary supplements: perspectives on science, safety, and potential regulatory approaches. J Diet Suppl. 2020;17(5):493\u2013502. https:\/\/doi.org\/10.1080\/19390211.2020.1777244.","journal-title":"J Diet Suppl"},{"key":"11282_CR6","unstructured":"Canadian Cannabis Survey 2019 - Summary. Health Canada. 2019. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/publications\/drugs-health-products\/canadian-cannabis-survey-2019-summary.html. Cited 2021 May 31"},{"key":"11282_CR7","unstructured":"MacKeen D. What Are the Benefits of CBD? The New York Times. 2019 Oct 16. Cited 2021 May 31."},{"key":"11282_CR8","unstructured":"Velasquez-Manoff M. Can CBD Really Do All That? The New York Times. 2019. May 14 Cited 2021 May 31."},{"key":"11282_CR9","unstructured":"Rabin RC. CBD Is Everywhere, but Scientists Still Don\u2019t Know Much About It. The New York Times 2019 Feb 25. Cited 2021 May 31."},{"key":"11282_CR10","unstructured":"Hsu T. Ads Pitching CBD as a Cure-All Are Everywhere. Oversight Hasn\u2019t Kept Up. The New York Times. 2019 Aug 13. Cited 2021 May 31."},{"key":"11282_CR11","unstructured":"CBD oil as health treatment: We answer 5 questions about cannabidiol products. CBC. 2019. Cited 2021 May 31."},{"key":"11282_CR12","unstructured":"Caulfield T. CBD oil products promise miracle cures. But does science support the hype? NBC News. 2019 Mar 17. Cited 2021 May 31."},{"key":"11282_CR13","doi-asserted-by":"publisher","unstructured":"Goodman S, Wadsworth E, Schauer G, Hammond D. Use and Perceptions of Cannabidiol Products in Canada and in the United States. Cannabis Cannabinoid Res. 2020. In Press. https:\/\/doi.org\/10.1089\/can.2020.0093.","DOI":"10.1089\/can.2020.0093"},{"key":"11282_CR14","unstructured":"FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy. United States Food and Drug Administration. 2020 Mar 27. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms. Cited 2021 May 31"},{"key":"11282_CR15","unstructured":"Health products containing cannabis or for use with cannabis: Guidance for the Cannabis Act, the Food and Drugs Act, and related regulations. Health Canada. 2018. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/applications-submissions\/guidance-documents\/guidance-cannabis-act-food-and-drugs-act-related-regulations\/document.html. Cited 2021 May 31."},{"issue":"11","key":"11282_CR16","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1007\/s10072-020-04514-2","volume":"41","author":"B Fiani","year":"2020","unstructured":"Fiani B, Sarhadi KJ, Soula M, Zafar A, Quadri SA. Current application of cannabidiol (CBD) in the management and treatment of neurological disorders. Neurol Sci. 2020 Nov 1;41(11):3085\u201398. https:\/\/doi.org\/10.1007\/s10072-020-04514-2.","journal-title":"Neurol Sci"},{"issue":"1","key":"11282_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s42238-019-0012-y","volume":"2","author":"R Khan","year":"2020","unstructured":"Khan R, Naveed S, Mian N, Fida A, Raafey MA, Aedma KK. The therapeutic role of Cannabidiol in mental health: a systematic review. J Cannabis Res. 2020 Jan 2;2(1):2. https:\/\/doi.org\/10.1186\/s42238-019-0012-y.","journal-title":"J Cannabis Res"},{"issue":"4","key":"11282_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1176\/appi.ps.202000189","volume":"72","author":"CN Stanciu","year":"2021","unstructured":"Stanciu CN, Brunette MF, Teja N, Budney AJ. Evidence for use of cannabinoids in mood disorders, anxiety disorders, and PTSD: a systematic review. Psychiatr Serv. 2021 Apr 1;72(4):429\u201336. https:\/\/doi.org\/10.1176\/appi.ps.202000189.","journal-title":"Psychiatr Serv"},{"key":"11282_CR19","unstructured":"The Cannabis Act and Cannabis regulations - Promotion prohibitions. Health Canada. 2018. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-medication\/cannabis\/laws-regulations\/promotion-prohibitions.html. Cited 2021 May 31."},{"key":"11282_CR20","unstructured":"Consolidated federal laws of Canada, Cannabis Act. Justice Laws Canada. 2020. Available from: https:\/\/laws-lois.justice.gc.ca\/eng\/acts\/c-24.5\/page-4.html#h-77140. Cited 2021 May 31."},{"key":"11282_CR21","unstructured":"What You Need to Know (And What We\u2019re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD. United States Food and Drug Administration. 2021 Feb 8. Available from: https:\/\/www.fda.gov\/consumers\/consumer-updates\/what-you-need-know-and-what-were-working-find-out-about-products-containing-cannabis-or-cannabis. Cited 2021 May 31."},{"key":"11282_CR22","unstructured":"FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concerns. United States Food and Drug Administration. 2020. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-warns-15-companies-illegally-selling-various-products-containing-cannabidiol-agency-details. Cited 2021 May 31"},{"key":"11282_CR23","unstructured":"Kronbauer B. Bif Naked launched an unlicensed CBD brand that claims it can help defend against Coronavirus. Vancouver Is Awesome. 2020 Mar 16. Cited 2021 May 31."},{"key":"11282_CR24","unstructured":"Lamers M. Canada proposes \u2018Cannabis Health Products\u2019 category for humans and pets, paving way for large new market. Marijuana Business Daily. 2019 Jun 19. Cited 2021 May 31."},{"issue":"1","key":"11282_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/10584609.1993.9962963","volume":"10","author":"Z Pan","year":"1993","unstructured":"Pan Z, Kosicki GM. Framing analysis: an approach to news discourse. Polit Commun. 1993;10(1):55\u201375. https:\/\/doi.org\/10.1080\/10584609.1993.9962963.","journal-title":"Polit Commun"},{"issue":"8","key":"11282_CR26","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/j.socscimed.2011.12.045","volume":"74","author":"B Van Gorp","year":"2012","unstructured":"Van Gorp B, Vercruysse T. Frames and counter-frames giving meaning to dementia: a framing analysis of media content. Soc Sci Med. 2012;74(8):1274\u201381. https:\/\/doi.org\/10.1016\/j.socscimed.2011.12.045.","journal-title":"Soc Sci Med"},{"key":"11282_CR27","unstructured":"Subramaniam V. CBD-craze drives Canadian pot firms to hop on the hemp bandwagon. Financial Post. 2019 Feb 19. Cited 2021 May 31."},{"key":"11282_CR28","unstructured":"Howatt B, Snider-Adler M. What you need to know about CBD and the workplace. The Globe and Mail. 2019 May 15. Cited 2021 May 31."},{"key":"11282_CR29","unstructured":"Bedore C. CBD: Why people are turning to this popular pot product. Global News. 2019 Feb 22. Cited 2021 May 31."},{"key":"11282_CR30","unstructured":"Young L. What you need to know about CBD, the non-intoxicating cannabis chemical. Global News. 2918 Dec 1. Cited 2021 May 31."},{"key":"11282_CR31","unstructured":"Fleming A. Cannabis health products are everywhere \u2013 but do they live up to the hype? The Guardian. 2018. Cited 2021 May 31."},{"key":"11282_CR32","unstructured":"Eisenstein M. The reality behind cannabidiol\u2019s medical hype. Nature. 2019 Aug 28. Cited 2021 May 31."},{"issue":"1","key":"11282_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s42238-021-00069-x","volume":"3","author":"MA Zenone","year":"2021","unstructured":"Zenone MA, Snyder J, Crooks VA. What are the informational pathways that shape people\u2019s use of cannabidiol for medical purposes? J Cannabis Res. 2021;3(1):13. https:\/\/doi.org\/10.1186\/s42238-021-00069-x.","journal-title":"J Cannabis Res"},{"key":"11282_CR34","unstructured":"Stea JN, Marshall T. Cannabis: Misinformation about CBD can be life-threatening. The Conversation. 2019 Jul 9. Cited 2021 May 31."},{"issue":"S3","key":"11282_CR35","doi-asserted-by":"publisher","first-page":"S294","DOI":"10.2105\/AJPH.2020.305768","volume":"110","author":"M Zenone","year":"2020","unstructured":"Zenone M, Snyder J, Caulfield T. Crowdfunding Cannabidiol (CBD) for Cancer: hype and misinformation on GoFundMe. Am J Public Health. 2020;110(S3):S294\u20139. https:\/\/doi.org\/10.2105\/AJPH.2020.305768.","journal-title":"Am J Public Health"},{"issue":"10","key":"11282_CR36","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.20977","volume":"3","author":"EC Leas","year":"2020","unstructured":"Leas EC, Hendrickson EM, Nobles AL, Todd R, Smith DM, Dredze M, et al. Self-reported Cannabidiol (CBD) use for conditions with proven therapies. JAMA Netw Open. 2020;3(10):e2020977. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.20977.","journal-title":"JAMA Netw Open"},{"key":"11282_CR37","unstructured":"Greenberg S, Gremillion T. Buyer beware: False medical claims about CBD and COVID-19. The Hill. 2020 May 18. Cited 2021 May 31."},{"key":"11282_CR38","unstructured":"White CM. No, CBD is not a miracle molecule that can cure coronavirus, just as it won\u2019t cure many other maladies its proponents claim. The Conversation. 2020 Apr 15. Cited 2021 May 31."},{"key":"11282_CR39","unstructured":"Compliance and enforcement policy for the Cannabis Act. Health Canada. 2018. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-medication\/cannabis\/laws-regulations\/compliance-enforcement-policy-cannabis-act\/policy.html. Cited 2021 May 31."},{"issue":"4","key":"11282_CR40","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1089\/can.2019.0101","volume":"5","author":"J Corroon","year":"2020","unstructured":"Corroon J, MacKay D, Dolphin W. Labeling of Cannabidiol products: a public health perspective. Cannabis Cannabinoid Res. 2020;5(4):274\u20138. https:\/\/doi.org\/10.1089\/can.2019.0101.","journal-title":"Cannabis Cannabinoid Res"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11282-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-11282-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11282-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T20:05:06Z","timestamp":1625169906000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11282-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["11282"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-11282-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1285"}}